UK cost agency rejects drugs from AstraZeneca, Bristol and Roche

See on Scoop.itAdvocacy Action & Issues in Cancer

LONDON (Reuters) – Britain’s healthcare cost watchdog NICE said on Friday it was not able to recommend a new diabetes drug from Bristol-Myers Squibb and AstraZeneca, and has asked for more information from the companies.The National Institute for…

Heather Swift‘s insight:

Very interesting article.  Please share YOUR thoughts.

See on medcitynews.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: